PharmaCann to close Denver grow facility, cut 132 jobs. Posted on March 26, 2026 PharmaCann Inc. filed a letter to the Colorado labor officials Friday PharmaCann Inc. is laying off 132 employees from a North Denver marijuana grow facility this spring, six months after the business was acquired by an expanding Minneapolis cannabis company. The company filed a letter to the Colorado labor officials Friday saying the business will close its 5131 Franklin St. site on May 20 and cut the 132 positions there. Late last year, PharmaCann Inc.'s assets in Colorado were acquired by a Minneapolis-based company, Vireo Health Inc., in an all-stock transaction. Vireo valued the shares used in the deal at $49 million. Vireo has grown to have 41 active Colorado dispensaries, the company says. Read The Rest Of This Article On Denver Business Journal, Click Here Stay up-to-date! Get all the news and info straight into your inbox that you need to help grow your business.

Closure of Denver cannabis growhouse will bring 132 layoffs. PharmaCann, the parent company for LivWell, will close its production facility near the National Western Center. Mar. 23, 2026, 5:37 pm 2 min. read Cannabis is pictured in a December 2022 file photo. (Kevin J. Beaty/Denverite) Kevin J. Beaty/Denverite By Tom Hesse A major cannabis company will close its facility in north Denver and lay off 132 employees in May. PharmaCann Inc., which is the parent company of LivWell, detailed the job losses in a March 20 notice to the state of Colorado. The 132 layoffs include employees who work in cultivation, data, farming and production, according to the notice. "The entire Facility will close on May 20, 2026. The action is expected to be permanent," chief manufacturing officer Nathan Fete wrote in the notification. The production and distribution facility is located at 5141 N. National Western Drive. PharmaCann, which is based in Illinois, merged with LivWell in 2022. In December, a company called Vireo Growth Inc. announced it was buying PharmaCann's retail properties in Colorado. That deal gave the Minneapolis-based Vireo control of 41 Colorado dispensaries at a cost of $49 million in stock, according to the Vireo press release. Vireo Growth stock was trading around 40 cents per share on Monday. Marijuana sales have been on the decline for years in Colorado, according to state figures. Sales peaked in 2021 at around $2.2 billion according to the state revenue department, but have been on a downward trajectory since then. In 2025, sales totaled just over $1.3 billion. Tom Hesse is a reporter for CPR News.

Innovative Industrial Properties, a cannabis-focused REIT, has resolved litigation with PharmaCann over lease defaults. The settlement includes monetary judgments and mandates property turnover by late May 2026 for locations in New York, Pennsylvania and Ohio. The company is in discussions with prospective tenants for all three properties. IIP executed 122,000 square feet of new leases in March 2026 as part of its portfolio enhancement plan. The company has re-leased all six properties previously held by PharmaCann and Gold Flora, and reached tentative agreements for four 4Front assets totalling 488,000 square feet. The company reported new defaults: Cannabist missed March rent on one Pennsylvania property representing 2.7% of 2025 revenues, whilst Battle Green defaulted on an Ohio property representing 2.9% of revenues. IIP will use security deposits to cover these payments.